USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$28.86 USD
-0.53 (-1.80%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $28.86 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, USANA Health Sciences, Inc. has a PEG ratio of 0.92 compared to the Medical - Drugs industry's PEG ratio of 1.32.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
USNA 28.86 -0.53(-1.80%)
Will USNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USNA
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
USANA Health (USNA) Upgraded to Buy: Here's Why
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USNA or ZTS: Which Is the Better Value Stock Right Now?
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
USANA Health Sciences (USNA) Q2 Earnings and Revenues Top Estimates
Other News for USNA
Insider Sell Alert: David Mulham Sells Shares of Usana Health Sciences Inc (USNA)
USANA Health Sciences: Hiya's Potential Is Showing
Usana Health Sciences Inc (USNA) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...
Usana signals major compensation plan overhaul and product launches while repaying debt and achieving 11% sales growth
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript